3.20Open3.20Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover313.42%IV-32.16%PremiumNov 15, 2024Expiry Date6.68Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7903Delta0.0577Gamma1.51Leverage Ratio-0.0888Theta-0.0029Rho-1.20Eff Leverage0.0046Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet